Reading is good for you...
Reading about what's good for you is even better.
August 8, 2022
August 10, 2022
August 2, 2022
Get your Xgeva delivered at your door for FREE
Xgeva (Denosumab) belongs to a family of medications known as monoclonal antibodies. Specifically, it is a RANK ligand inhibitor.
We accept all insurance plans
**Actual price will depend on the insurance coverage in your province
Xgeva (Denosumab) belongs to a family of medications known as monoclonal antibodies. Specifically, it is a RANK ligand inhibitor. It is used to decrease the risk of fractures or bone pain as a result of certain cancers spreading into the bone. Xgeva (Denosumab) is also used to treat a type of bone tumour called giant cell tumour of bone, which cannot be treated by surgery or where surgery is not the best option, for adults and adolescents (aged 13 to 17 years) whose bones have stopped growing.
Xgeva (Denosumab) may also be used to treat hypercalcemia (high levels of calcium in the blood) for people with cancer that has not responded to treatment with bisphosphonates.
Xgeva (Denosumab) works by reducing the amount of bone your body breaks down, making your bones less likely to break. In people with hypercalcemia, Xgeva (Denosumab) decreases the amount of calcium in the blood by reducing the breakdown of bones.
Xgeva (Denosumab) may be available under multiple brand names and/or in several different forms. Any specific brand name of Xgeva (Denosumab) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Xgeva (Denosumab) may not be used for all of the conditions discussed here.
Your doctor may have suggested Xgeva (Denosumab) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given Xgeva (Denosumab), speak to your doctor. Do not stop using Xgeva (Denosumab) without consulting your doctor.
Do not give Xgeva (Denosumab) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to use Xgeva (Denosumab) if their doctor has not prescribed it.
The recommended dose for preventing fractures or bone pain for adults with cancer is 120 mg injected subcutaneously (under the skin) every 4 weeks.
For adults or adolescents who are being treated for giant cell tumour of bone, or for treatment of hypercalcemia, the recommended dose is 120 mg injected subcutaneously every 4 weeks, with an additional dose being given 1 week and 2 weeks after the first dose during the first month of treatment only. Xgeva (Denosumab) is injected under the skin of the upper arm, upper thigh, or abdomen. Your doctor may show you how to give yourself the injections, or a health care professional will inject the medication for you.
The solution for injection should be clear and colourless-to-slightly-yellow. If it is cloudy or you can see particles in the solution, do not use it. Allow the medication to warm to room temperature for 15 - 30 minutes before you inject it. Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is important that Xgeva (Denosumab) be used exactly as recommended by your doctor. If you miss an appointment to receive Xgeva (Denosumab), contact your doctor as soon as possible to reschedule your appointment. If you are injecting Xgeva (Denosumab) yourself and miss a dose, use it as soon as you remember. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Xgeva (Denosumab) is stored in the refrigerator, protected from light and temperatures above 25°C. Do not allow Xgeva (Denosumab) to freeze. Keep it out of the reach of children. When removed from the refrigerator, it can also be stored at room temperature for 30 days. It should be allowed to reach room temperature before injecting. Do not shake Xgeva (Denosumab).
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Xgeva (Denosumab). If you are concerned about side effects, discuss the risks and benefits of Xgeva (Denosumab) with your doctor.
The following side effects have been reported by at least 1% of people taking Xgeva (Denosumab). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of these side effects listed below don't happen very often, they could lead to serious problems if you do not check with your doctor or seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Xgeva (Denosumab).
Each single-use vial containing 1.7 mL of a sterile, preservative-free, clear, colourless-to-slightly yellow solution, formulated at pH 5.2, contains 120 mg of Xgeva (Denosumab). Nonmedicinal ingredients: sorbitol, acetate, water for injection (USP), and sodium hydroxide to a pH of 5.2.
Do not use Xgeva (Denosumab) if you:
There may be an interaction between Xgeva (Denosumab) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Xgeva (Denosumab). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Xgeva (Denosumab).
Calcium and vitamin D: While using Xgeva (Denosumab), it is important that you are receiving enough calcium and vitamin D to maintain blood calcium levels. Your doctor will recommend a dose of calcium and vitamin D based on your needs. If you develop symptoms of low blood calcium levels (muscle spasms, twitches, or cramps; numbness or tingling in the fingers, toes, or around the mouth) while using Xgeva (Denosumab), contact your doctor immediately or get immediate medical attention.
Fractures: As with other medications in this class, Xgeva (Denosumab) may contribute to a type of rare fracture of the long bone in the thigh (femur). If you experience new or unusual pain in the groin, hip, or thigh area, contact your doctor as soon as possible.
Fractures of the bones in the spine (vertebra) have been reported after stopping Xgeva (Denosumab). Do not stop treatment with Xgeva (Denosumab) without checking with your doctor first.
Infections: Xgeva (Denosumab) may cause infections that in some cases are serious and require hospitalization. Contact your doctor at once if you develop signs of an infection such as fever, abdominal pain, earache, painful urination, or blood in the urine, or if you notice a red, swollen, or tender area on the skin. People who are taking medications that suppress the immune system (e.g., Prednisone, Azathioprine, anticancer medications) or who have a suppressed immune system may be more at risk of developing infections.
Severe jawbone problems: Xgeva (Denosumab) may cause problems with your upper or lower jaw. You may be at a higher risk of these problems if you have cancer that has spread to the bones, are taking certain medications (e.g., prednisone, anticancer medications), are having radiation treatments, have poor oral hygiene, or are having a tooth extracted. Your doctor may recommend that you see a dentist before starting Xgeva (Denosumab). It is important to practice good oral hygiene while taking Xgeva (Denosumab).
Pregnancy: The safety of Xgeva (Denosumab) for use during pregnancy has not been established. Xgeva (Denosumab) is not recommended for use during pregnancy. If you become pregnant while using Xgeva (Denosumab), contact your doctor immediately. For women taking Xgeva (Denosumab), an effective form of birth control should be used during treatment and for at least 5 months after the last dose of Xgeva (Denosumab).
Breast-feeding: Xgeva (Denosumab) has not been studied for use by breast-feeding mothers. It is not known if Xgeva (Denosumab) passes into breast milk. If you are a breast-feeding mother and are taking Xgeva (Denosumab), it may affect your baby. Xgeva (Denosumab) is not recommended for use by women who are breast-feeding.
Children and adolescents: The safety and effectiveness of using Xgeva (Denosumab) have not been established for children. Xgeva (Denosumab) is only recommended for adolescents with giant cell tumour of bone whose bones have stopped growing. Xgeva (Denosumab) has not been studied in children and adolescents with other cancers that have spread to bone.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022